Showing 321 - 340 results of 5,484 for search '"Pharmaceutical"', query time: 0.06s Refine Results
  1. 321
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326

    The impact of the centralized volume-based procurement policy on Chinese pharmaceutical manufacturing firms' R&D investment: A difference-in-differences approach. by Fangjun Qiu, Shouming Chen, Yujia Li, Xianjing Wang, Mengfei Zhu

    Published 2025-01-01
    “…Centralized drug procurement is a common practice worldwide to relieve the healthcare burden and promote high-quality development in the pharmaceutical industry. However, scholars have not yet reached an agreement on whether centralized procurement can facilitate the innovation activities of pharmaceutical firms. …”
    Get full text
    Article
  7. 327

    Determination of Atenolol and Trimetazidine in Pharmaceutical Tablets and Human Urine Using a High Performance Liquid Chromatography-Photo Diode Array Detection Method by Walaa El-Alfy, Omnia A. Ismaiel, Magda Y. El-Mammli, Abdalla Shalaby

    Published 2019-01-01
    “…Linearity was obtained over a concentration range of (1.0-100 μg/mL) for both analytes in standard solutions and the method was successfully applied for determination of target analytes in their pharmaceutical tablets. Excellent linearity was also obtained over concentration ranges of (0.25-25 μg/mL) and (0.5-25 μg/mL) in human urine for TMZ and ATN, respectively. …”
    Get full text
    Article
  8. 328
  9. 329

    Medical students’ exposure to and attitudes towards product promotion and incentives from the pharmaceutical industry in 2019: a national cross-sectional study in France by Maxime Esvan, Benjamin Bastian, Martin Molina, Adeline Boëffard

    Published 2022-07-01
    “…Objectives To measure medical students’ exposure to pharmaceutical product promotion and incentives nationwide, and to evaluate students’ attitudes towards the pharmaceutical industry, access to education on promotional strategies and knowledge of institutional policies about drug company-student relationships.Design Cross-sectional survey based on a 48-item anonymous questionnaire.Setting All 37 French medical schools, from March to April 2019.Participants French medical students in their 4th year of study and beyond, having studied exclusively in France.Main outcome measure Cumulative frequency of students’ exposure to pharmaceutical product promotion and incentives.Secondary outcome measures Exposure within the last 6 months, attitudes regarding interactions with the industry, access to education on pharmaceutical product promotion and incentives and knowledge of institutional policies.Results 6280 responses were analysed (10.4% out of a total of 60 550 eligible students). 5992 students (96.3% poststratification, 99% CI (96.1% to 96.5%)) had already been exposed to pharmaceutical product promotion and incentives and 4650 (78.1%, 99% CI (77.7% to 78.6%)) within the last 6 months. 5140 students (85.4%, 99% CI (84.8% to 85.8%)) had met a pharmaceutical representative. …”
    Get full text
    Article
  10. 330

    Validation of an RPHPTLC-Densitometric Method Using Silica Gel 60 RP18WF254 for Simultaneous Determination of Nicotinamide in Selected Pharmaceutical Formulations by Małgorzata Dołowy, Alina Pyka

    Published 2015-01-01
    “…Developed method is accurate and precise (CV<3%) and may be successfully applied for the quality control of pharmaceutical formulations containing nicotinamide in the presence of its derivatives, such as N,N-diethylnicotinamide, N-methylnicotinamide, and nicotinic acid.…”
    Get full text
    Article
  11. 331

    Identifying and ranking the circular supply chain implementation challenges using pythagorean fuzzy SWARA approach (case of study: pharmaceutical industry of Guilan province) by Samaneh Rash, Mostafa Ebrahimpour Azbari, Mohammad Rahim Ramazanian

    Published 2023-11-01
    “…We used the proposed method in the pharmaceutical industry of the Guilan province.Findings: In the final results of the research, Strategic Challenges (SCs) and operational and environmental challenges are prioritized.Originality/Value: This research serves as a step for industry practitioners to efficiently and effectively adopt a CSC.…”
    Get full text
    Article
  12. 332

    Comparative efficacy and safety of 20 intravenous pharmaceutical intervention for prevention of etomidate-induced myoclonus: a systematic review and Bayesian network meta-analysis by Lu Chen, Lu Chen, Pengxiang Zhou, Pengxiang Zhou, Zhengqian Li, Ziyang Wu, Suodi Zhai, Suodi Zhai

    Published 2025-01-01
    “…We included randomized controlled trials (RCTs) comparing intravenous pharmaceutical interventions to prevent EIM with placebo, no intervention, or another pharmaceutical intervention.ResultsForty-eight RCTs involving 4,768 participants randomly assigned to 20 intravenous pharmaceutical interventions and normal saline were included. …”
    Get full text
    Article
  13. 333

    Comparing rates and characteristics of emergency department presentations related to pharmaceutical opioid poisoning in Australia: a study protocol for a retrospective observational study by Dan I Lubman, Suzanne Nielsen, Tina Lam, Janneke Berecki-Gisolf, Jane Hayman, Paul Sanfilippo

    Published 2020-09-01
    “…Introduction and aims Pharmaceutical opioids are an important contributor to the global ‘opioid crisis’, and are implicated in 70% of Australia’s opioid-related mortality. …”
    Get full text
    Article
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338
  19. 339
  20. 340